Biopharmaceuticals
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Aim & Scope
This section is dedicated to research on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted. Download Section Flyer
Keywords
- Peptides
- Proteins
- RNA
- DNA
- Nucleic Acids
- Aptamers
- Carbohydrates
- Glycans
- Polysaccharides
- Macromolecules
- Chemical Synthesis
- Ribonucleoproteins
- Antibodies
- Phages
- Viruses
- Therapeutic Tools
- Peptidomimetics
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Protein and Peptide-Based Drug Delivery (Deadline: 20 November 2025)
- Antiplatelet Therapy in Inflammatory Diseases (Deadline: 20 November 2025)
- Peptide Synthesis and Drug Development: Exploring Progress and Potential (Deadline: 25 November 2025)
- HIV and Viral Hepatitis Prevention, Treatment and Coinfection, 2nd Edition (Deadline: 25 December 2025)
- Advances in Non-Coding RNAs as Prognostic Biomarkers, Therapeutic Targets, and Regulatory Mechanisms in Cancer (Deadline: 25 December 2025)
- Exosome and Biotherapeutic Strategies for Dermatological and Oncological Skin Complications (Deadline: 25 December 2025)
- Advances in Regulatory Mechanisms and Therapeutic Potential of Non-Coding RNAs in Neurodegenerative Diseases (Deadline: 31 December 2025)
- 2D and 3D Culture Systems: Current Trends and Biomedical Applications (Deadline: 25 January 2026)
- Pharmaceutical Blood Products (Deadline: 31 January 2026)
- Protein Silencing in Pharmaceutical Applications (Deadline: 25 February 2026)
- Innovations in Integrin-Targeted Drug Delivery: From Peptide Conjugates to Dual-Action Therapeutics (Deadline: 28 February 2026)
- Therapeutic Applications of Micro-RNA in Cancer Management (Deadline: 27 March 2026)
- Stem Cells in Oncology: Emerging Targets for Therapy (Deadline: 31 March 2026)
- Targeting Enzymes in Drug Design and Discovery (Deadline: 20 April 2026)
- Next Generation Approaches for Cartilage Regeneration (Deadline: 25 April 2026)
- Pleiotropic Agents and Their Therapeutic Potential in Gastroenterology, Angiology, and Musculoskeletal Disorders (Deadline: 25 April 2026)
- Peptide-Based Therapeutics: Targeting Amylin, Calcitonin, and Related Receptors (Deadline: 25 May 2026)
- DNA Repair Targeted Therapy: New Advances in Cancer Treatment (Deadline: 25 May 2026)
- Targeting the NLRP3: From Novel Inhibitor Design to Clinic Trials and Therapeutic Applications (Deadline: 31 May 2026)
- Epigenetic Regulatory Mechanisms and Applications of Non-Coding RNAs in Chemoresistance and Metabolic Disorders (Deadline: 15 June 2026)
- Characterization and Quality Control of Biopharmaceuticals Using the Multi-Attribute Method (MAM): Advantages and Challenges (Deadline: 30 June 2026)
- New Structural, Biophysical and Computational Perspectives on the Use of Proteins in Drug Design and Discovery (Deadline: 31 October 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
